Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Amedisys Inc (AMED)

Amedisys Inc (AMED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,946,550
  • Shares Outstanding, K 32,754
  • Annual Sales, $ 2,236 M
  • Annual Income, $ -9,750 K
  • EBIT $ 166 M
  • EBITDA $ 225 M
  • 60-Month Beta 0.73
  • Price/Sales 1.26
  • Price/Cash Flow 14.06
  • Price/Book 2.34

Options Overview Details

View History
  • Implied Volatility 14.19% ( -1.88%)
  • Historical Volatility 23.12%
  • IV Percentile 11%
  • IV Rank 21.26%
  • IV High 40.37% on 12/17/24
  • IV Low 7.13% on 01/11/24
  • Put/Call Vol Ratio 11.91
  • Today's Volume 1,497
  • Volume Avg (30-Day) 2,457
  • Put/Call OI Ratio 5.21
  • Today's Open Interest 59,405
  • Open Int (30-Day) 72,967

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 1.07
  • Number of Estimates 7
  • High Estimate 1.14
  • Low Estimate 1.00
  • Prior Year 0.94
  • Growth Rate Est. (year over year) +13.83%

Price Performance

See More
Period Period Low Period High Performance
1-Month
82.15 +10.40%
on 12/20/24
91.98 -1.40%
on 12/02/24
-0.72 (-0.78%)
since 11/29/24
3-Month
82.15 +10.40%
on 12/20/24
97.89 -7.35%
on 11/06/24
-5.82 (-6.03%)
since 09/30/24
52-Week
82.15 +10.40%
on 12/20/24
98.95 -8.34%
on 07/26/24
-4.36 (-4.59%)
since 12/29/23

Most Recent Stories

More News
Stock market today: Wall Street slips as the 'Magnificent 7' weighs down the market

Stocks are closing lower as Wall Street ends a holiday-shortened week on a down note

NFLX : 905.00 (-0.28%)
CVS : 43.88 (-1.37%)
META : 594.88 (-0.82%)
NVDA : 139.37 (+1.72%)
DLTR : 75.56 (-0.57%)
$SPX : 5,929.16 (-0.70%)
MU : 86.04 (-2.79%)
$IUXX : 21,298.13 (-0.81%)
UNH : 508.36 (-0.32%)
MSFT : 426.95 (-0.83%)
AMED : 90.67 (+0.79%)
WBA : 9.30 (-3.33%)
Stocks Settle Lower as Megacap Tech Stocks Retreat

The S&P 500 Index ($SPX ) (SPY ) Friday closed down -1.11%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.77% and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.36%. March E-mini...

GOOGL : 192.30 (-0.24%)
MDLZ : 59.67 (-0.90%)
AAPL : 253.34 (-0.88%)
AVGO : 237.03 (-1.95%)
HRL : 31.31 (-1.70%)
KHC : 30.37 (-1.01%)
LW : 64.80 (-3.28%)
$IUXX : 21,298.13 (-0.81%)
ZNH25 : 108-305 (+0.48%)
MSFT : 426.95 (-0.83%)
TSLA : 422.92 (-2.02%)
ESH25 : 5,982.75 (-0.73%)
Stocks Retreat on a Selloff in Magnificent Seven Tech Stocks

The S&P 500 Index ($SPX ) (SPY ) today is down -1.16%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.71%. March E-mini S&P futures...

GOOGL : 192.30 (-0.24%)
AAPL : 253.34 (-0.88%)
AVGO : 237.03 (-1.95%)
CVX : 143.16 (-0.58%)
SLB : 37.67 (-0.34%)
LW : 64.80 (-3.28%)
$IUXX : 21,298.13 (-0.81%)
ZNH25 : 108-305 (+0.48%)
MSFT : 426.95 (-0.83%)
OXY : 48.66 (+0.21%)
TSLA : 422.92 (-2.02%)
ESH25 : 5,982.75 (-0.73%)
Stocks Pressured by Higher Bond Yields and Tech Stock Weakness

The S&P 500 Index ($SPX ) (SPY ) today is down -0.73%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.31%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.22%. March E-mini S&P futures...

GOOGL : 192.30 (-0.24%)
AVGO : 237.03 (-1.95%)
CVX : 143.16 (-0.58%)
SLB : 37.67 (-0.34%)
LW : 64.80 (-3.28%)
$IUXX : 21,298.13 (-0.81%)
ZNH25 : 108-305 (+0.48%)
MSFT : 426.95 (-0.83%)
OXY : 48.66 (+0.21%)
TSLA : 422.92 (-2.02%)
ESH25 : 5,982.75 (-0.73%)
FANG : 160.90 (+1.62%)
UnitedHealth, Amedisys Stocks In Focus As $3.3B Merger Deadline Extended Amid DOJ Wrangling: Retail Guarded

The merger announced in Jun. 2023 involved UnitedHealth’s Optum unit buying Amedysis for $100 per share in cash, a 26% premium over the latter’s then-prevailing stock price.

XLV : 137.46 (-1.07%)
AMED : 90.67 (+0.79%)
IHF : 48.05 (-0.75%)
UNH : 508.36 (-0.32%)
Do Options Traders Know Something About Amedisys (AMED) Stock We Don't?

Investors in Amedisys, Inc. AMED need to pay close attention to the stock based on moves in the options market lately. That is because the Jun 20, 2025 $45 Put had some of the highest implied volatility...

AMED : 90.67 (+0.79%)
Justice Department sues to block UnitedHealth Group's $3.3 billion purchase of Amedisys

The Justice Department is suing to block UnitedHealth Group’s $3.3 billion purchase of Amedisys

AMED : 90.67 (+0.79%)
$SPX : 5,929.16 (-0.70%)
$DOWI : 42,726.72 (-0.62%)
$IUXX : 21,298.13 (-0.81%)
UNH : 508.36 (-0.32%)
Stock market today: Wall Street drifts lower as the Trump trade cools

U.S. stocks slipped as juice ran out for the torrid “Trump trade” that swept Wall Street following Donald Trump’s presidential victory

HUM : 255.18 (-0.18%)
NVDA : 139.37 (+1.72%)
AMED : 90.67 (+0.79%)
CI : 275.59 (-1.12%)
JPM : 240.48 (-0.29%)
$SPX : 5,929.16 (-0.70%)
LYV : 131.72 (-0.10%)
$DOWI : 42,726.72 (-0.62%)
$IUXX : 21,298.13 (-0.81%)
TSN : 57.16 (-1.40%)
UNH : 508.36 (-0.32%)
Amedisys: Q3 Earnings Snapshot

Amedisys: Q3 Earnings Snapshot

AMED : 90.67 (+0.79%)
Amedisys Reports Third Quarter 2024 Financial Results

AMED : 90.67 (+0.79%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure,...

See More

Key Turning Points

3rd Resistance Point 91.02
2nd Resistance Point 90.56
1st Resistance Point 90.26
Last Price 90.67
1st Support Level 89.50
2nd Support Level 89.04
3rd Support Level 88.74

See More

52-Week High 98.95
Fibonacci 61.8% 92.53
Last Price 90.67
Fibonacci 50% 90.55
Fibonacci 38.2% 88.57
52-Week Low 82.15

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar